Specialty-Tier Drug Denied or Unaffordable? The Tiering-Exception Appeal
High-cost specialty drugs land on the top formulary tier, where coinsurance can run to hundreds or thousands of dollars a fill. A tiering exception asks the plan to charge you the lower cost-sharing of a preferred tier. Here is how the request works under 42 CFR 423.578, what your prescriber has to say, and how it differs across Medicare Part D, commercial, and Medicaid plans.
When a drug sits on a plan's specialty tier, the problem is usually not a flat 'no', it is the cost: specialty tiers often use coinsurance (a percentage of the drug's price) instead of a flat copay, so a single fill can cost hundreds or thousands of dollars. The tool for this is a tiering exception, a formal request that the plan apply the lower cost-sharing of a preferred tier to your drug. In Medicare Part D, tiering exceptions are governed by 42 CFR 423.578, and your prescriber must submit a supporting statement that the preferred (lower-tier) alternatives would not be as effective for you, would cause adverse effects, or both. Commercial plans run an equivalent process under 45 CFR 147.136 and, for employer plans, 29 CFR 2560.503-1, though many plans place true specialty tiers outside the tiering-exception rules, in which case the fight becomes a formulary exception or a medical-necessity appeal. The exact deadline is on your notice; Part D appeal clocks are much shorter than the commercial 180-day floor. This is general information, not legal or medical advice.
A specialty drug is not denied the way a routine claim is denied. More often the plan technically 'covers' it, then places it on the highest formulary tier and charges you a percentage of its list price. Because specialty drugs are expensive by definition, that percentage can turn into a bill you cannot pay, which functions as a denial in everything but name. This page is about the specific lever built for that situation: the tiering exception, a request that the plan charge you as if the drug sat on a cheaper, preferred tier. It also serves as the hub for the four pharmacy-side barriers plans use, non-formulary status, step therapy, specialty tiering, and quantity limits, each of which has its own dedicated appeal page linked below. Everything here is general information to help you prepare, file, and track your own appeal, not legal or medical advice.
What a 'specialty tier' actually is
Health and drug plans sort covered medications into tiers, and each tier has its own cost-sharing. Lower tiers (generics and preferred brands) usually carry a flat copay, a fixed dollar amount per fill. The top of the ladder is typically a specialty tier, reserved for high-cost drugs, and here plans frequently switch from a flat copay to coinsurance: you pay a set percentage of the drug's negotiated price. On a drug that costs thousands of dollars a month, even a modest percentage becomes a very large number.
Under the Medicare Part D disclosure rule, 42 CFR 423.128, a plan must disclose its formulary, including any tiered structure and the utilization-management procedures it uses, and must tell you the process for obtaining an exception to the formulary or to the tiered cost-sharing structure. In other words, the tiering rules and the exception process are supposed to be spelled out in your plan materials. If you cannot find them, that itself is worth raising.
The practical takeaway is that a specialty-tier problem is usually a cost problem, not a coverage problem, and the cost problem has its own named remedy.
The tiering exception: the core lever
A tiering exception asks the plan to apply the cost-sharing of a lower, preferred tier to a drug that sits on a higher one. For Medicare Part D, this is set out in 42 CFR 423.578(a): a plan that uses a tiered formulary must have procedures for enrollees to request that a non-preferred drug be covered at a preferred tier's cost-sharing when that drug is medically necessary. CMS describes it plainly: a tiering exception should be requested to obtain a non-preferred drug at the lower cost-sharing terms that apply to a preferred tier.
The pivot of the request is your prescriber's supporting statement. Under 42 CFR 423.578, a prescribing physician or other prescriber must provide an oral or written statement that the preferred drug(s) for your condition either would not be as effective for you as the requested drug, would have adverse effects for you, or both. That clinical statement is what turns a billing complaint into a coverage-determination request the plan has to decide on the merits.
One honest limit: the regulation does not guarantee that a supporting statement produces a yes. And plans are generally permitted to exclude certain very-high-cost drugs, sometimes an entire dedicated specialty tier, from tiering exceptions. When a drug is genuinely outside the tiering-exception rules, the productive path is usually a formulary exception (to waive a rule) or a medical-necessity appeal, not a tiering request that the plan can decline on structural grounds. Reading the plan's own exception policy tells you which lane you are in.
Part D vs commercial vs Medicaid
The three big coverage systems handle specialty-tier disputes differently, and the differences change your deadlines and your route.
| Medicare Part D | Commercial / ACA plan | Medicaid | |
|---|---|---|---|
| Core rule | 42 CFR 423.578 (exceptions) | 45 CFR 147.136; ERISA plans add 29 CFR 2560.503-1 | State Medicaid rules + federal Medicaid due-process |
| Named remedy | Tiering exception (coverage determination) | Internal appeal; tiering/formulary process varies by plan | Fair hearing and plan grievance/appeal |
| Prescriber statement | Required supporting statement | Letter of medical necessity in practice | Prescriber documentation of necessity |
| Appeal clock | Short (see notice); redetermination is the first level | Federal floor at least 180 days for internal appeal | Set by state; often short for fair-hearing |
| Outside review | Independent Review Entity, then further levels | External review by an IRO | State fair hearing |
How to request a tiering exception
The mechanics are similar across plans: you (or your prescriber or authorized representative) ask the plan for the exception, and your prescriber supplies the clinical statement. In Part D, the request is a type of coverage determination; once the plan has the prescriber's supporting statement, CMS describes decision windows of 24 hours for an expedited request or 72 hours for a standard request. Commercial plans decide internal appeals on their own timeframes, which the plan documents state.
When a tiering exception is not the right tool
Three fact patterns commonly send people to a different page. If the drug is not on the formulary at all, you want a formulary exception, not a tiering exception. If the plan is forcing you to try and fail a cheaper drug first, that is step therapy, and you want a step-therapy override. If the plan is capping the amount or days' supply, that is a quantity limit, with its own exception. Each of these has a dedicated guide below, and all four run through the same basic engine: a prescriber statement plus a formal exception request, decided as a coverage determination or internal appeal.
Apellica helps patients prepare and file these pharmacy exceptions and appeals, assembling the prescriber statement, the plan's own criteria, and the record into a single filing, and tracking the deadlines. Apellica is not a law firm or a medical provider; your prescriber supplies the clinical judgment. You can start at /start.
Frequently asked questions
What is a tiering exception?
It is a request that your plan charge you the lower cost-sharing of a preferred tier for a drug that currently sits on a higher, more expensive tier. In Medicare Part D it is governed by 42 CFR 423.578 and requires your prescriber to state that the preferred alternatives would not be as effective for you or would cause adverse effects.
Why is my specialty drug so expensive even though it is 'covered'?
Specialty tiers often use coinsurance, a percentage of the drug's price, instead of a flat copay. On a high-cost drug that percentage can be very large, so the drug is technically covered but effectively unaffordable. A tiering exception targets exactly that cost-sharing.
Can any specialty drug get a tiering exception?
Not always. Plans are generally allowed to exclude certain very-high-cost drugs, and sometimes a dedicated specialty tier, from tiering exceptions. When that is the case, the productive route is usually a formulary exception or a medical-necessity appeal instead. Your plan's exception policy states which drugs are eligible.
Does my doctor have to be involved?
Yes. The exception turns on a prescriber's supporting statement about medical necessity, that the preferred, lower-tier drugs would not be as effective for you or would cause adverse effects. Without that clinical statement the plan can decline to treat it as a coverage determination on the merits.
How fast will the plan decide?
For a Medicare Part D exception, CMS describes decision windows of 24 hours for an expedited request and 72 hours for a standard request once the plan has the prescriber's supporting statement. Commercial plans decide internal appeals on the timeframes in your plan documents. Ask for an expedited decision if a delay could seriously harm your health.
How long do I have to appeal a specialty-tier denial?
It depends on the plan type. Medicare drug-plan appeal clocks are short, the first level (redetermination) is requested within a window stated on your notice, far shorter than the commercial internal-appeal floor of at least 180 days under 45 CFR 147.136. Always use the exact deadline on your denial notice; it controls.
What if the exception is denied?
You move to the next level. In Part D that is a redetermination, then review by an Independent Review Entity, then further levels. In a commercial plan you file the internal appeal and then, for medical-necessity and similar denials, an external review by an independent organization whose decision binds the plan.
Sources
- 42 CFR 423.578, Medicare Part D exceptions process (tiering and formulary)
- 42 CFR 423.128, Part D dissemination of plan information (formulary and exception disclosure)
- CMS, Prescription drug exceptions (tiering and formulary exceptions)
- Medicare.gov, Appeals in a Medicare drug plan (levels of appeal)
- 45 CFR 147.136, Internal claims and appeals and external review
Got a denial of your own?
Two-minute intake. We confirm fit for guided support or self-guided package within one business day.
Start Your Appeal